Skip to content
POM-V Prescription Required

Equimidine 10 mg/ml Solution for Injection for Horses

Active ingredient: Detomidine Hydrochloride

Form

Injection

Species

Horses

Manufacturer

Provivo Oy

VMD MA No.

25929/4000

What it's used for

Sedation and slight analgesia of horses with or without butorphanol to facilitate the handling of horses for examination, minor surgical interventions and...

Full indications, dosage and side effects ↓
View official SPC (PDF)

The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.

Paying less for Detomidine Hydrochloride

  1. 1

    Ask your vet for a written prescription

    They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.

  2. 2

    Fill it at a registered online retailer

    The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.

Prescription required

Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.

Clinical information

Equimidine 10 mg/ml Solution for Injection for Horses — SPC Details

Source: VMD Summary of Product Characteristics (SPC). Last updated 26 Mar 2026.

Sedation and slight analgesia of horses with or without butorphanol to facilitate the
handling of horses for examination, minor surgical interventions and other
manipulations.
Equimidine is also indicated for use with ketamine for short duration anaesthesia to
carry out surgical procedures such as castration.
Give by slow intravenous injection. As this is a multi dose bottle the surface of the
bung should be cleaned and disinfected prior to penetration of the bung with a sterile
needle. The needle should be passed carefully into the bottle prior to withdrawal of
the dose and then withdrawn carefully to avoid damage. (See also 4.5, above).
Return bottle to cardboard carton after use.
The following procedure is recommended. Use two sterile needles, one to fill the
syringe from the bottle and one to inject the patient. Once the required dose has
been withdrawn from the vial, the syringe should be removed from the needle. A
separate sterile needle should be inserted into the injection site and the syringe
connected to it. The needles should be discarded.
Use alone for sedation
Dosage table
Anticipated Level of
Sedation
LightModerateProfoundDosage (IV) mcg/kg10 – 2020 – 4040 – 80Dose (IV) ml/100kg0.1 – 0.20.2 – 0.40.4 – 0.8Commencement of
effect (mins)
321Duration of action (hrs)0.5 – 10.5 - 10.5 – 2
Use with butorphanol for sedation
Use only after reading all the information provided in section 4, Clinical Particulars.
Dosage 0.12 ml /100kg (12 mcg/kg detomidine hydrochloride) intravenously followed
within 5 minutes by 25 mcg/kg butorphanol (e.g. 0.25 ml/100kg of a 10mg/ml
solution) intravenously. Clinical experience has shown that 5 mg detomidine HCl (0.5
ml of the product) and 10 mg (e.g. 1 ml of a 10 mg/ml solution) of butorphanol affords
effective and very safe sedation in horses above 200 kg bodyweight.
Warnings
Do not use combination in horses with a history of liver disease. The combination
should not be used in pregnant mares or in animals suffering from colic.
Routine cardiac auscultation should be performed prior to use of this combination.
Do not use in horses with a pre-existing cardiac dysrhythmia or bradycardia.
Mild to severe ataxia may be encountered but clinical studies have shown that horses
are unlikely to collapse. Normal precautions should be observed to prevent patient
self-injury.
Use with ketamine (short duration anaesthesia)
Use only after reading all the information provided in section 4, Clinical Particulars.
Ketamine should not be used as the sole anaesthetic agent in horses. It is important
to adhere to the following procedures to obtain satisfactory surgical anaesthesia.
Administer the product at a dose rate of 20 mcg/kg by slow intravenous injection.
Allow 5 minutes for the horse to become deeply sedated then administer ketamine at
a dose rate of 2.2 mg/kg as an intravenous bolus. Onset of anaesthesia is gradual

Revised: December 2014
AN: 00351/2014
with the horse taking approximately 1 minute to become recumbent. (In large fit
horses recumbency may take up to 3 minutes).
Anaesthesia will deepen for a further 1-2 minutes and during this time the horse
should be left quietly.
Horses regain sternal recumbency approximately 20 minutes after ketamine injection.
The period of surgical anaesthesia is about 10-15 minutes and if it is necessary to
prolong anaesthesia, thiopentone sodium can be given as IV boluses of 1 mg/kg as
required. Total doses of 5 mg/kg (5 x 1 mg/kg injections) have been given. Doses
greater than this may reduce the quality of recovery. Thiopentone can also be given
(as above) to deepen anaesthesia if needed.
The horse should be allowed to stand in its own time. Ataxia may be a problem if it
stands prematurely and it should be encouraged to remain recumbent.
To facilitate handling and administration some horses have received acepromazine
by intramuscular injection at a dose rate of 0.03 mg/kg at least 45 minutes prior to
induction of anaesthesia.
Warnings
Allow sedation to develop. The two agents should never be co-administered in the
same syringe.
It is recommended that feed is withdrawn for at least 12 hours prior to anaesthesia.
Excitable horses can be poor subjects for anaesthesia. Considerate, quiet and
careful handling during the administration of the agents is necessary so as to cause
the minimum upset possible. If sedation with the product fails to occur then the
procedure should be abandoned. In these circumstances ketamine must not be
injected into the horse
Do not use with sympathomimetic amines.
Do not use with potentiated sulphonamides.
Do not mix with other products.
Do not use in animals with cardiac abnormalities (including pre-existing atrio-
ventricular blocks and coronary insufficiency) or respiratory disease.
Do not use in animals with liver insufficiency or renal failure.
Do not use in animals with general health problems (e.g. dehydration).
Do not use in the last 3 months of pregnancy.
Do not use in combination with butorphanol in horses suffering from colic.
Do not offer food or water until drug effect has passed.
See also sections 4.7 and 4.8.

Revised: December 2014
AN: 00351/2014
Injection of detomidine may cause the following side effects:








As with other sedatives, in rare cases paradoxical reactions (excitations) can
develop.
At doses above 40 g/kg bodyweight, the following symptoms can also be observed:
sweating, pilo-erection and tremor of muscles. Transient penis prolapse in stallions
and geldings.
In very rare cases horses may show mild symptoms of colic following administration
of alpha-2 sympathomimetics because substances of this class transiently inhibit the
motility of the intestines. Detomidine should be prescribed with caution in horses
which present with signs of colic or impaction.
A diuretic effect is usually observed within 45 to 60 minutes after treatment.
None.

i) Special precautions for use in animals
As sedation begins, horses may start to sway and lower the head rapidly while
remaining standing. In order to prevent self injury the location where the
procedure is to be performed should be chosen carefully.
Animals suffering from shock or liver or kidney disease should only be treated
according to the benefit/risk assessment by the responsible veterinarian.
The product should not be used in animals suffering from cardiac diseases (with
pre-existing bradycardia and risk of atrioventricular block), respiratory-, liver- or
renal insufficiencies, shock or any other extraordinary stress conditions.
Detomidine/butorphanol combination should not be used in horses with a
history of liver disease or cardiac irregularities.
It is recommended that feed should be withheld for at least 12 hours prior to
anaesthesia.
Water or food should not be offered to treated animals until the drug effect has
passed.
In painful procedures detomidine should be used only in combination with an
analgesic or a local anaesthetic.
While waiting for sedation, animals should remain in calm surroundings.
In case of sustained effect it is necessary to protect the animal from heat or
cold.
ii) Special precautions to be taken by the person administering the veterinary
medicinal product to animals
In the case of accidental oral intake or self-injection, seek medical advice
immediately and show the package leaflet to the doctor but DO NOT DRIVE as
sedation and changes in blood pressure may occur.
Avoid skin, eye or mucosal contact. The use of impermeable gloves is
advisable especially in the case of damaged skin.
Immediately after exposure wash the exposed skin with large amounts of fresh
water.
Remove contaminated clothes that are in direct contact with skin.
In the case of accidental contact of the product with eyes, rinse with large
amounts of fresh water. If symptoms occur, seek the advice of a doctor.
If pregnant women handle the product, special caution should be observed not
to self-inject as uterine contractions and decreased foetal blood pressure may
occur after accidental systemic exposure.

Revised: December 2014
AN: 00351/2014
Advice to doctors
Detomidine hydrochloride is an alpha-2-adrenoreceptor agonist. Symptoms
after absorption may involve clinical effects including dose-dependent sedation,
respiratory depression, bradycardia and hypotension, a dry mouth and
hyperglycaemia. Ventricular arrhythmias have also been reported. Respiratory
and haemodynamic symptoms should be treated symptomatically.
The concurrent use of certain potentiated sulphonamides may cause potentially fatal
dysrhythmias. Do not use in combination with sulphonamides.
The product should be used with care with other sedatives and anaesthetics because
of an additive/synergistic effect.
Concurrent use of other sedatives should proceed only after consultation of the
warnings and precautions of the product concerned and according to the benefit/risk
assessment of the veterinary surgeon.
Detomidine should not be used in combination with sympathomimetic amines such
as adrenaline, dobutamine and ephedrine.
Where anaesthesia is induced with a combination of detomidine and ketamine, prior
to maintenance with halothane, the effects of halothane may be delayed and care
must be taken to avoid overdosage.
When detomidine is used as a premedicant prior to general anaesthesia, the product
may delay the onset of induction.

Revised: December 2014
AN: 00351/2014
Meat and offal: 2 days
Milk: 12 hours
5.

This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.

Medication costs adding up?

Pet insurance can cover prescription medications. Find the right policy for your pet.

Compare insurance

Find cheaper vets near you

Compare vet consultation prices in your area. Save on procedures and get a prescription to buy medications online.